Heartflow, Inc. HTFL
55.80 USD -0.86 (-1.52%)
At closeNov 11, 2026, 8:24 AM EST
56.15 +0.35 +0.63%
Pre-market · Nov 11, 8:24 AM ET
54.50 Day range 57.26
20.13 52-week range 60.56
- YTD
- +91.42%
- 1 year
- +64.94%
Benzinga news
benzinga.com Heartflow To Present DECIDE Registry Data Showing 34% Reduction In Major Cardiovascular Events With AI Plaque Analysis, At AHA Scientific Sessions 2026 First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone. GAMEFILM data highlight…
benzinga.com Elucid Bioimaging Says Co Is Aware Of A Lawsuit Filed By Heartflow, On October 22, 2026. Elucid Will Respond To And Defend Against The Claims In The Lawsuit Through The Appropriate Legal Channels Elucid Bioimaging Inc. ("Elucid") today reaffirmed its commitment to advancing its mission – the prediction and personalization of the prevention of heart attack and stroke – and its confidence in…
benzinga.com Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64 Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $45 to $64.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.
benzinga.com UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55 UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.
benzinga.com HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results and raised its full-year outlook.- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $37 to $45.
- benzinga.com Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40 Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and raises the price target from $35 to $40.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.- benzinga.com Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45 Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $38 to $45.
benzinga.com JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45 JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $45.- benzinga.com Wells Fargo Maintains Overweight on HeartFlow, Raises Price Target to $39 Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $37 to $39.
benzinga.com Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
benzinga.com Stifel Maintains Buy on HeartFlow, Raises Price Target to $45 Stifel analyst Rick Wise maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $40 to $45.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
benzinga.com Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
benzinga.com HeartFlow Q2 2026 Earnings Call Transcript HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved…
benzinga.com CORRECTION: HeartFlow Q2 Adj. EPS $(0.07) Beats $(0.13) Estimate, Sales $53.190M Miss $56.642M Estimate HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 97.49 percent increase over losses of $(2.79)…- benzinga.com HeartFlow Raises FY2026 Sales Guidance from $218.000M-$222.000M to $246.000M-$250.000M vs $230.073M Est HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $246.000 million-$250.000 million vs $230.073 million estimate.
benzinga.com This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, initiations. See other analysts' views on HTFL, SKYH, FTH.- benzinga.com Baird Initiates Coverage On HeartFlow with Outperform Rating, Announces Price Target of $34 Baird analyst David Rescott initiates coverage on HeartFlow (NASDAQ:HTFL) with a Outperform rating and announces Price Target of $34.
benzinga.com Freedom Capital Markets Initiates Coverage On HeartFlow with Buy Rating, Announces Price Target of $37 Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) with a Buy rating and announces Price Target of $37.- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Lowers Price Target to $37 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and lowers the price target from $43 to $37.
benzinga.com Wells Fargo Maintains Overweight on HeartFlow, Raises Price Target to $37 Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $37.
benzinga.com Transcript: HeartFlow Q1 2026 Earnings Conference Call - benzinga.com HeartFl232.000M vsow Raises FY2026 Sales Guidance from $218.000M-$222.000M to $228.000M-$ $220.412M Est HeartFlow (NASDAQ:HTFL) raises FY2026 sales outlook from $218.000 million-$222.000 million to $228.000 million-$232.000 million vs $220.412 million estimate.
- benzinga.com HeartFlow Q1 Adj. EPS $(0.16) Beats $(0.19) Estimate, Sales $52.587M Beat $49.705M Estimate HeartFlow (NASDAQ:HTFL) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. The company reported quarterly sales of $52.587 million…
benzinga.com Earnings Scheduled For May 14, 2026 
benzinga.com Earnings Volatility Watch: 10 Stocks With More Than 17% Implied Moves This Week Options markets are pricing post-earnings moves between 17.74% and 42.50% on ten small/mid caps reporting May 11-14. NIQ tops the list.- benzinga.com Heartflow Sues Cleerly Over Alleged Patent Infringement Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed a patent infringement lawsuit against Cleerly, Inc. in the…
benzinga.com JP Morgan Maintains Overweight on HeartFlow, Lowers Price Target to $35 JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lowers the price target from $40 to $35.- benzinga.com Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $43 Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $40 to $43.
benzinga.com Signet Jewelers, Rivian Automotive, Five Below And Other Big Stocks Moving Higher On Thursday U.S. stocks drop, with Dow Jones down 150 points. Signet Jewelers stock rose 11.8% after beating earnings estimates. Other stocks also record gains.- benzinga.com Wells Fargo Maintains Overweight on HeartFlow, Lowers Price Target to $35 Wells Fargo analyst Larry Biegelsen maintains HeartFlow (NASDAQ:HTFL) with a Overweight and lowers the price target from $38 to $35.
- benzinga.com Earnings Scheduled For March 18, 2026
- benzinga.com Earnings Scheduled For November 12, 2025
benzinga.com Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday